Qiagen (QGEN)
50.00
+1.10 (2.25%)
Upcoming Events
Latest Headlines
Qiagen posts $548M in Q3 2026 net sales amid pending EQT deal
October 21, 2026 5:48 PM - StreetInsider
EQT to acquire Qiagen in €10.8 billion all-cash takeover
October 21, 2026 5:45 PM - StreetInsider
QIAGEN reports preliminary Q3 2026 results
October 21, 2026 5:44 PM - BizWire
QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer
October 21, 2026 5:43 PM - BizWire
EQT to Acquire Qiagen For EUR46.50/share In Cash - Bloomberg
October 21, 2026 5:39 PM - StreetInsider
EQT nears €9.6 billion deal to acquire Qiagen - Bloomberg
October 21, 2026 3:39 PM - StreetInsider
Qiagen shares surge on report of advanced EQT takeover talks
October 20, 2026 1:42 PM - StreetInsider
EQT Is Said To Be In Advanced Talks To Buy Testing Firm Qiagen - Bloomberg
October 20, 2026 12:35 PM - StreetInsider
QIAGEN hosts global tuberculosis summit amid funding pressures
October 13, 2026 4:06 PM - StreetInsider
QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis
October 13, 2026 4:05 PM - BizWire
QIAGEN NV (QIA:GR) (QGEN) PT Raised to EUR44 at Morgan Stanley
October 9, 2026 6:10 AM - StreetInsider
Qiagen NV (QGEN) PT Raised to $50 at Baird
October 8, 2026 7:23 AM - StreetInsider
Barclays Upgrades Qiagen NV (QGEN) to Overweight
October 6, 2026 6:11 AM - StreetInsider
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel
September 28, 2026 1:30 AM - BizWire
Qiagen launches compact QIAmini sample prep system for small labs
September 24, 2026 4:05 PM - StreetInsider
QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation
September 24, 2026 4:05 PM - BizWire
Qiagen calls shareholder vote on new CEO board appointment
September 18, 2026 4:05 PM - StreetInsider
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board
September 18, 2026 4:05 PM - BizWire
TPG, Bain Weigh Offers For Qiagen, Manager Magazin Reports
September 17, 2026 7:15 AM - StreetInsider
UBS Assumes Qiagen NV (QGEN) at Neutral
September 9, 2026 6:07 AM - StreetInsider
Form 6-K QIAGEN N.V. For: Sep 30
September 9, 2026 6:02 AM - SEC Filing
Jury finds Parse Biosciences willfully infringed 10x Genomics patents
August 28, 2026 2:41 PM - StreetInsider
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
August 28, 2026 2:39 PM - PR NewsWire
QIAGEN launches QIAsymphony Connect nucleic acid extraction platform
August 27, 2026 4:11 PM - StreetInsider
QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction
August 27, 2026 4:05 PM - BizWire
Qiagen names Jonathan Pratt as CEO amid takeover talks
August 24, 2026 9:58 AM - StreetInsider
Qiagen names Jonathan Pratt as CEO, replacing Thierry Bernard
August 24, 2026 9:47 AM - StreetInsider
QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
August 24, 2026 9:47 AM - BizWire
Qiagen (QGEN) Halted, News Pending
August 24, 2026 9:46 AM - StreetInsider
EQT And KKKR Said Among Firms Considering Bids For Qiagen - Bloomberg
August 24, 2026 9:41 AM - StreetInsider
FDA clears Qiagen bloodstream infection panel for U.S. market
August 10, 2026 4:05 PM - StreetInsider
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
August 10, 2026 4:05 PM - BizWire
Qiagen NV (QGEN) PT Raised to $40 at Stifel
August 7, 2026 10:28 AM - StreetInsider
Qiagen NV (QGEN) PT Raised to $50 at JPMorgan
August 7, 2026 9:09 AM - StreetInsider
Form 6-K QIAGEN N.V. For: Jun 30
August 7, 2026 6:20 AM - SEC Filing
Form 6-K QIAGEN N.V. For: Jun 30
August 7, 2026 6:19 AM - SEC Filing
Form 6-K QIAGEN N.V. For: Jun 30
August 7, 2026 6:17 AM - SEC Filing
Qiagen NV (QGEN) PT Raised to $40 at Barclays
August 7, 2026 4:55 AM - StreetInsider
QIAGEN NV (QIA:GR) (QGEN) PT Raised to EUR40 at Morgan Stanley
August 7, 2026 3:59 AM - StreetInsider
Qiagen NV (QGEN) PT Raised to $48 at Jefferies
August 6, 2026 3:23 PM - StreetInsider
Qiagen (QGEN) spreader of 1500 contracts of August 45 and 3K contracts of September 45 calls
August 6, 2026 2:18 PM - StreetInsider
Qiagen (QGEN) Tops Q2 EPS by 2c
August 5, 2026 4:43 PM - StreetInsider
Qiagen tops Q2 outlook with flat sales, reaffirms 2026 guidance
August 5, 2026 4:05 PM - StreetInsider
QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook
August 5, 2026 4:05 PM - BizWire
Citi Assumes Qiagen NV (QGEN) at Neutral
July 30, 2026 10:03 AM - StreetInsider
Qiagen (QGEN) spreader of 10K contracts of August 40 and 20K contracts of August 45 calls
July 27, 2026 2:46 PM - StreetInsider
Full Article List
